129 related articles for article (PubMed ID: 12798170)
1. Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.
Yilmaz B; Kadioğlu YY; Aksoy Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):103-9. PubMed ID: 12798170
[TBL] [Abstract][Full Text] [Related]
2. Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.
Xu Y; Keith B; Grem JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):263-70. PubMed ID: 15018786
[TBL] [Abstract][Full Text] [Related]
3. Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.
Lin NM; Zeng S; Ma SL; Fan Y; Zhong HJ; Fang L
Acta Pharmacol Sin; 2004 Dec; 25(12):1584-9. PubMed ID: 15569401
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
Marangon E; Sala F; Caffo O; Galligioni E; D'Incalci M; Zucchetti M
J Mass Spectrom; 2008 Feb; 43(2):216-23. PubMed ID: 17941128
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2', 2'-difluorodeoxyuridine in rat plasma by UFLC-MS/MS.
Sun Y; Zhen L; Peng Y; Wang J; Fei F; Aa L; Jiang W; Pei X; Lu L; Liu J; Wang G; Hao K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():4-13. PubMed ID: 29558739
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in human plasma by liquid chromatography.
Yilmaz B; Kadioğlu YY; Aksoy Y
Anal Biochem; 2004 Sep; 332(2):234-7. PubMed ID: 15325290
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography.
Keith B; Xu Y; Grem JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 785(1):65-72. PubMed ID: 12535839
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.
Zhong B; Gibson EG; Davis A; Roussel MF; Stewart CF
J Pharm Biomed Anal; 2021 May; 198():114025. PubMed ID: 33744463
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites.
Delauter BJ; Ramanathan RK; Egorin MJ; Stover LL; Zuhowski EG; Plunkett W; Zamboni WC
Pharmacotherapy; 2000 Oct; 20(10):1204-7. PubMed ID: 11034044
[TBL] [Abstract][Full Text] [Related]
10. Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection.
Freeman KB; Anliker S; Hamilton M; Osborne D; Dhahir PH; Nelson R; Allerheiligen SR
J Chromatogr B Biomed Appl; 1995 Mar; 665(1):171-81. PubMed ID: 7795789
[TBL] [Abstract][Full Text] [Related]
11. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.
Kerr JZ; Berg SL; Dauser R; Nuchtern J; Egorin MJ; McGuffey L; Aleksic A; Blaney S
Cancer Chemother Pharmacol; 2001 May; 47(5):411-4. PubMed ID: 11391856
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.
Kirstein MN; Hassan I; Guire DE; Weller DR; Dagit JW; Fisher JE; Remmel RP
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):136-42. PubMed ID: 16584929
[TBL] [Abstract][Full Text] [Related]
13. Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
Vainchtein LD; Rosing H; Thijssen B; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(14):2312-22. PubMed ID: 17577879
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
Gamblin TC; Egorin MJ; Zuhowski EG; Lagattuta TF; Herscher LL; Russo A; Libutti SK; Alexander HR; Dedrick RL; Bartlett DL
Cancer Chemother Pharmacol; 2008 Sep; 62(4):647-53. PubMed ID: 18040687
[TBL] [Abstract][Full Text] [Related]
15. Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.
Lanz C; Früh M; Thormann W; Cerny T; Lauterburg BH
J Sep Sci; 2007 Aug; 30(12):1811-20. PubMed ID: 17638352
[TBL] [Abstract][Full Text] [Related]
16. Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer.
Masumori N; Kunishima Y; Hirobe M; Takeuchi M; Takayanagi A; Tsukamoto T; Itoh T
Jpn J Clin Oncol; 2008 Mar; 38(3):182-5. PubMed ID: 18270381
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study to optimize the intravesical administration of gemcitabine.
Gontero P; Cattel L; Paone TC; Milla P; Berta G; Fiorito C; Carbone F; Medana C; Tizzani A
BJU Int; 2010 Dec; 106(11):1652-6. PubMed ID: 20590553
[TBL] [Abstract][Full Text] [Related]
18. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
[TBL] [Abstract][Full Text] [Related]
19. High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MS.
Wickremsinhe ER; Lee LB; Schmalz CA; Torchia J; Ruterbories KJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():117-22. PubMed ID: 23831704
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma.
Khoury H; Deroussent A; Reddy LH; Couvreur P; Vassal G; Paci A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):71-8. PubMed ID: 17851141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]